TNXP - .556 Pre-market now at .61/.61. Tonix Pharmaceuticals to Present Breakthrough Therapy Designated-PTSD Program and Corporate Update at the 2017 BIO CEO & Investor Conference http://stockcharts.com/c-sc/sc?s=TNXP&p=D&b=5&g=0&i=t13396117224&r=1486646808745 http://stockcharts.com/c-sc/sc?s=TNXP&p=W&b=5&g=0&i=t45329287476&r=1486646788191